Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
Annals of Neurology|November 10, 2010
Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosisKonstantin E Balashov, Latt Latt Aung, Adi Vaknin-Dembinsky, et al.
Journal of Neuroimmunology|January 18, 2015
Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patientsYifat Amir Levy, Karin Mausner-Fainberg, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2015
Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosisHanna Charbit, Arriel Benis, Bella Geyshis, et al.
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Journal of the Neurological Sciences|July 31, 2020
Description of 3 patients with myasthenia gravis and COVID-19Netaniel Rein, Nitzan Haham, Efrat Orenbuch-Harroch, et al.
Harefuah|March 22, 2013
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital]Adi Vaknin-Dembinsky, Netta Levin, Noa Raz, et al.
Journal of the Neurological Sciences|December 16, 2014
Tumefactive demyelination following in vitro fertilization (IVF)Adi Vaknin-Dembinsky, Yuval Bdolah, Dimitrios Karussis, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Neurology|May 29, 2024
Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settingsAriel Rechtman, Tal Freidman-Korn, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|September 11, 2025
A predictive model for triple negative optic neuritis patients: Identifying the subset of patients with favorable outcomesAriel Rechtman, Tal Friedman-Korn, Sol Zamir, et al.
Annals of Neurology|November 10, 2010
Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosisKonstantin E Balashov, Latt Latt Aung, Adi Vaknin-Dembinsky, et al.
Journal of Neuroimmunology|January 18, 2015
Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patientsYifat Amir Levy, Karin Mausner-Fainberg, Adi Vaknin-Dembinsky, et al.
Multiple Sclerosis and Related Disorders|December 14, 2019
QKI-V5 is downregulated in CNS inflammatory demyelinating diseasesIris Lavon, Ina Leykin, Hanna Charbit, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2015
Sex-specific prediction of interferon beta therapy response in relapsing-remitting multiple sclerosisHanna Charbit, Arriel Benis, Bella Geyshis, et al.
Frontiers in Immunology|August 8, 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathwayAriel Rechtman, Omri Zveik, Lyne Shweiki, et al.
Journal of the Neurological Sciences|July 31, 2020
Description of 3 patients with myasthenia gravis and COVID-19Netaniel Rein, Nitzan Haham, Efrat Orenbuch-Harroch, et al.
Harefuah|March 22, 2013
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital]Adi Vaknin-Dembinsky, Netta Levin, Noa Raz, et al.
Journal of the Neurological Sciences|December 16, 2014
Tumefactive demyelination following in vitro fertilization (IVF)Adi Vaknin-Dembinsky, Yuval Bdolah, Dimitrios Karussis, et al.
Pageof 9